You are here: Home » Current Affairs » Coronavirus » News
PMC Bank scam: Shiv Sena MP Sanjay Raut's wife appears before ED
Business Standard

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

Topics
Bharat Biotech | Serum Institute of India | Coronavirus Vaccine

Sohini Das  |  Mumbai 



Krishna Ella, chairman & MD,  Bharat Biotech
Krishna Ella, chairman & MD, Bharat Biotech

A vaccine war has surfaced as India prepares for a massive inoculation drive to prevent the spread of coronavirus, which has killed more than 150,000 in the country. A day after two vaccines got restricted emergency use authorisation from the drug regulator, one of them — — has raised the pitch against competition. This comes in the backdrop of wide criticism against the approval granted to Bharat Biotech, which is yet to complete its phase three trial and present efficacy data.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, January 05 2021. 01:31 IST

RECOMMENDED FOR YOU